News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Jeffrey Sanders, MD

Dr Sanders is a resident at the University of Oklahoma School of Community Medicine in Tulsa.

Articles by Jeffrey Sanders, MD

Insights From the 2022 AAPL Annual Meeting

ByBritta K. Ostermeyer, MD, MBA,Susan Hatters Friedman, MD, MSt, DFAPA,Joshua Friedman, MD, PhD,Jason Beaman, DO, MS, MPH,Katie Kruse, MD,Jeffrey Sanders, MD,Tessa Manning, MD,Elie G. Aoun, MD,Barry Wall, MD,Bethany Hughes, MD,Ren Belcher, MD,Charles Dike, FRCPsych, MBChB, MPH

January 19th 2023

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.

Latest Updated Articles

Trending on Psychiatric Times

Positive FDA Meeting for Abuse Deterrent Fentanyl Patch

“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples

The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth

Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD

Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?

© 2025 MJH Life Sciences^®

All rights reserved.